Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Cancer Epidemiol ; 36(5): e306-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22537764

ABSTRACT

BACKGORUND: Although increased serum levels of soluble interleukin-2 receptor (sIL-2R) and their clinical importance are well known in mature type lymphoproliferative disorders (LD), little data is available about such information in acute type hematological malignancies. METHODS: We examined the serum levels of sIL-2R in 57 adult patients with acute type leukemias: 32 with acute myeloid leukemia (AML), 14 acute lymphoblastic leukemia (ALL) and 11 chronic myelocytic leukemia in blast crisis (CMLBC), and in 29 adult patients with mature type LD, and assessed their cellular and clinical relevance in acute type leukemias. RESULTS: No significant differences were seen in the sIL-2R levels between acute type leukemias and mature type LD. In AML, serum sIL-2R levels were related to the cell surface CD4 expression on blast cells, and patients with higher levels ≧2000U/ml had a poorer prognosis (lower response to chemotherapy and shorter overall survival). CONCLUSIONS: These results suggest that serum sIL-2R level elevates in acute type leukemias like mature type LD, and increased sIL-2R levels in adult AML are correlated with certain biological and clinical characteristics.


Subject(s)
Blast Crisis/immunology , CD4 Antigens/blood , Leukemia, Myeloid, Acute/blood , Receptors, Interleukin-2/blood , Antigens, Surface/blood , Female , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/immunology , Leukemia, Myeloid, Acute/immunology , Leukemia, Myeloid, Acute/mortality , Lymphoproliferative Disorders/blood , Lymphoproliferative Disorders/immunology , Male , Middle Aged , Precursor Cell Lymphoblastic Leukemia-Lymphoma/blood , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , Prognosis , Receptors, Interleukin-2/immunology , Serum/immunology , Survival Rate
2.
Intern Med ; 48(10): 791-6, 2009.
Article in English | MEDLINE | ID: mdl-19443973

ABSTRACT

OBJECTIVE: Bacterial biofilms cause serious problems, such as antibiotic resistance and medical device-related infections. Recent reports indicate that Bacillus species potentially form biofilms and cause nosocomial bacteremia via catheter infection. Our objective was to investigate the relationship between nosocomial bacteremia caused by Bacillus species and biofilm formations. METHODS: Between 2001 and 2006, Bacillus cereus and Bacillus thuringiensis were isolated from blood samples of 21 patients with nosocomial bacteremia in two hospitals. The patients had underlying diseases such as cerebrovascular damage, malignant disease, or chronic obstructive lung disease and had high fever at the onset of bacteremia. After investigation, B. cereus and B. thuringiensis were isolated from patient's catheter tip, gauze, and hospital environment. Pulsed-field gel electrophoresis (PFGE) on 32 B. cereus and 7 B. thuringiensis isolates, microtiter biofilm assay and scanning electron microscopy (SEM) on 22 B. cereus isolates from patient's blood were performed. RESULTS: Molecular analysis by PFGE showed that 32 B. cereus strains had 21 patterns and 7 B. thuringiensis strains had 3 patterns. The PFGE patterns of B. thuringiensis and B. cereus in blood samples from 2 patients blood were similar to those from the same patient's catheter tip. The PFGE pattern of B. cereus from a hospital environment was similar to that from 2 patients' blood samples, and the PFGE pattern of B. thuringiensis from 2 hospital environments was similar to that from 2 patients' blood. The biofilm formations by 22 B. cereus isolates from patients' blood were confirmed by microtiter biofilm assay and SEM even at 24 hours. CONCLUSION: Our data indicate that various types of Bacillus species exist in hospital environments and the biofilm-forming strains potentially cause nosocomial bacteremia by catheter infection.


Subject(s)
Bacillus cereus/pathogenicity , Bacillus thuringiensis/pathogenicity , Bacteremia/microbiology , Biofilms/growth & development , Cross Infection/microbiology , Gram-Positive Bacterial Infections/microbiology , Aged , Aged, 80 and over , Bacillus cereus/classification , Bacillus cereus/genetics , Bacillus thuringiensis/classification , Bacillus thuringiensis/genetics , Catheter-Related Infections/microbiology , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , Electrophoresis, Gel, Pulsed-Field , Humans , Microscopy, Electron, Scanning
4.
Cancer Detect Prev ; 29(3): 256-9, 2005.
Article in English | MEDLINE | ID: mdl-15899555

ABSTRACT

We measured the levels of soluble interleukin-2 receptor (sIL-2R) in the serum of 53 patients with hematological malignancies (14 with acute leukemia, 10 myeloproliferative disorders, 21 non-Hodgkin's lymphoma and 8 multiple myeloma), 40 with non-hematological solid malignancies (24 with lung cancer, 11 digestive system cancer and 5 other cancers) and 95 healthy subjects as a control using an enzyme-linked immunosorbent assay. Both hematological and non-hematological neoplasms showed significantly higher sIL-2R levels than normal subjects (p<0.01). However, compared to solid malignancies, hematological neoplasms displayed a wide range of sIL-2R levels and extremely elevated values of sIL-2R were seen in certain cases. These results seem to suggest that sIL-2R levels may serve as one of non-invasive markers of differential diagnosis for patients with bulky mass lesions between hematological and solid malignancy.


Subject(s)
Biomarkers, Tumor/blood , Hematologic Neoplasms/diagnosis , Hematologic Neoplasms/pathology , Receptors, Interleukin-2/blood , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Diagnosis, Differential , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged
5.
J Infect Chemother ; 8(1): 106-8, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11957130

ABSTRACT

Invasive pulmonary aspergillosis is a serious problem in the treatment of patients with acute leukemia. A 52-year-old woman with acute myeloid leukemia developed invasive pulmonary aspergillosis during remission induction chemotherapy. Initially, we treated her with a continuous intravenous drip infusion of amphotericin B, together with itraconazole, given orally. A peripheral crescentic cavity formed in the fungal lesion after the number of neutrophils recovered, and we therefore performed a direct infusion of miconazole into the cavity transbronchially. The lung lesion resolved dramatically shortly after this treatment. In this patient, the transbronchial infusion of an antifungal agent seemed to have been very useful for bringing about prompt resolution of the fungal lesion.


Subject(s)
Amphotericin B/administration & dosage , Antifungal Agents/administration & dosage , Aspergillosis/drug therapy , Itraconazole/administration & dosage , Leukemia, Myeloid, Acute/complications , Lung Diseases, Fungal/drug therapy , Aspergillosis/etiology , Drug Therapy, Combination , Female , Humans , Lung Diseases, Fungal/etiology , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...